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tivecommons.org/licenses/by-nc-Summary Aims: Spontaneous bacterial peritonitis (SBP) is one of the most frequent compli-
cations of liver cirrhosis. Ascitic fluid lactoferrin has been proved to be a good diagnostic tool
for SBP. However, lactoferrin in ascites may be checked after antibiotic treatment in these pa-
tients. Our study aims to assess the utility of ascitic fluid lactoferrin levels for the diagnosis of
SBP after antibiotic treatment.
Materials and methods: Twenty-two ascites samples were collected from patients with
cirrhosis. Samples were examined for bacterial culture, lactoferrin concentration, and poly-
morphonuclear leukocyte count. Clinical symptoms and indications for ascitic paracentesis
were obtained from medical records. The diagnosis of SBP was based on an elevated ascitic
fluid polymorphonuclear leukocyte count of 250 cells/mm3.
Results: Four (18.1%) samples fulfilled the diagnostic criteria for SBP. Three ascites samples
showed a positive result for bacterial culture. Patients who received antibiotics for treatment
of SBP constituted Group B (n Z 9), whereas those who did not receive any antibiotics
comprised Group A (n Z 9). Lactoferrin concentration was significantly elevated (mean:
261.69  145.5 ng/mL) in the three cases with a positive bacterial culture compared to those
without SBP, in both Group A (mean: 19.64  6.32 ng/mL, p Z 0.002) and Group B (mean:
23.64  9.53 ng/mL, p Z 0.001).t of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Number 5, Fu-Hsin Street,
33, Taiwan.
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124 C.-H. Wu et al.Conclusion: After systemic antibiotic treatment, elevated lactoferrin levels in the ascites of
cirrhotic patients appear to be a promising predictor for the presence of SBP having positive
ascitic bacterial culture.
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Liver cirrhosis represents a terminal clinical stage of
chronic liver disease. Patients with liver cirrhosis are sus-
ceptible to a variety of complications. Ascites or accumu-
lation of fluid within the peritoneal cavity is one of the most
common complications [1]. Spontaneous bacterial perito-
nitis (SBP) is the infection of pre-existing ascitic fluid
without evidence of a secondary infection. The diagnosis of
SBP is based on a polymorphonuclear leukocyte (PMN) count
in ascitic fluid of 250 cells/mm3, irrespective of whether
the ascitic fluid indicates positive results on bacterial cul-
ture [2].
SBP leads to hospitalization of 10e30% of cirrhotic pa-
tients, and the mortality rate in this group approaches 30%
[3,4]. Owing to the high mortality rate, patients with SBP
should be started on empiric, broad-spectrum antibiotics
immediately. According to the 2012 American Association
for the Study of Liver Disease guidelines, in patients with
suspected SBP, empiric therapy should be initiated
promptly to maximize patient survival [5].
Lactoferrin is an iron-binding protein found in human
mucosal secretions as well as in the specific granules of
PMNs [6]. A previous study demonstrated the sensitivity and
specificity of fecal lactoferrin concentration for the
detection of intestinal inflammation [7]. In addition, mea-
surement of ascitic fluid lactoferrin levels is a reliable
biomarker for the presence of PMNs and detection of SBP in
patients with cirrhosis [8]. However, as prompt antibiotic
treatment is recommended when SBP is suspected, the
therapy may be initiated prior to abdominal paracentesis
for the collection of ascitic fluid in most cases, which can
adversely affect the lactoferrin concentration. Therefore,
the diagnostic role of ascitic lactoferrin levels after anti-
biotic treatment may be compromised and is unclear.
Moreover, patients with advanced cirrhosis are prone to
develop bacterial infections other than SBP, such as pneu-
monia or urinary tract infection, and may require antibiotic
treatment [9]. In the present study, we aimed to identify
the lactoferrin level after systemic antibiotic treatment for
SBP and other systemic infections.Materials and methods
Patients
The inclusion criteria were a known diagnosis of cirrhosis
and the presence of ascites. The major indication for
abdominal paracentesis was symptom relief to minimize thefeeling of abdominal fullness. Exclusion criteria included the
presence of other causes of neutrocytic ascites, such as
rupture of hepatocellular carcinoma, peritoneal carcino-
matosis, and hemorrhagic ascites.
Paracentesis
Paracentesis was performed under aseptic conditions, with
the patient in supine position and the puncture site in the left
or right lower quadrant. Ultrasonography was performed
prior to needle insertion to visualize the intra-abdominal
structures. No immediate or delayed complications such as
bleeding or hollow organ perforation were noted after the
abdominal puncture procedure. Concurrent collection of an
ascitesfluid samplewasperformed.Theascites sampleswere
used to measure total cell counts, PMN count, and albumin
levels, and for performing aerobic and anaerobic cultures.
Methods
A total of 22 patients with cirrhosis and ascites, who were
admitted to Chang Gung Memorial Hospital, Taoyuan,
Taiwan and fulfilled the inclusion criteria, were assessed.
The diagnosis of liver cirrhosis and ascites was based on
clinical and biochemical data, and ultrasonography find-
ings. The diagnosis of SBP was based on the PMN count
during the first paracentesis, when SBP was suspected, as
the symptoms such as fever, abdominal pain, or sepsis
existed and the samples were examined for cell counts and
bacterial culture. All the ascites samples collected during
the second paracentesis, which was performed for symp-
tom relief, were also examined for cell counts, bacterial
culture, and lactoferrin concentration. Patients were clas-
sified into three groups: nine patients with an ascitic fluid
PMN count of <250 cells/mm3, who did not initially receive
systemic antibiotic treatment (Group A); nine patients with
an ascitic fluid PMN count of <250 cells/mm3, who initially
received antibiotic treatment for reasons other than SBP
(Group B); and four patients with an ascitic fluid PMN count
of 250 cells/mm3 (Group C). Group C was further sub-
divided into culture-negative SBP (defined as Group Cn) and
culture-positive SBP (defined as Group Cp) groups. Bacte-
riological culture was performed using aerobic and anaer-
obic standard blood culture bottles. The medical history of
all patients was recorded, and all patients underwent a
clinical examination, routine laboratory investigations, and
an abdominal ultrasonographic examination. Aspirated as-
citic fluid samples were immediately processed for cell
counts (including total and differential cell counts), bac-
terial cultures, and biochemical assays. The lactoferrin
Table 1 Baseline characteristics of patients with liver
cirrhosis (N Z 22).
Group A
(n Z 9)a
Group B
(n Z 9)b
Group C
(n Z 4)c
Age (y) 55  10.5 63  17.7 56  11.0
Sex (M:F) 6:3 8:1 1:3
ChildePugh score 9  2.0 10  1.7 10  2.8
Fever 0 (0/9) 11.1 (1/9) 50 (2/4)
Abdominal pain 0 (0/9) 0 (0/9) 50 (2/4)
Encephalopathy 11.1 (1/9) 22.2 (2/9) 50 (2/4)
Data are presented as % (n/N ) or mean  SD, unless otherwise
indicated.
PMN Z polymorphonuclear leukocyte; SBP Z spontaneous
bacterial peritonitis.
a An ascitic fluid PMN count of <250 cells/mm3 in patients who
did not initially receive systemic antibiotic treatment.
b An ascitic fluid PMN count of <250 cells/mm3 in patients who
initially received antibiotic treatment for reasons other than
SBP.
c An ascitic fluid PMN count of 250 cells/mm3.
Lactoferrin in SBP after antibiotic treatment 125levels in ascitic samples were quantified using a human
lactoferrin enzyme-linked immunosorbent assay kit (ELISA)
according to the manufacturer’s instructions (Bethyl Labo-
ratories Inc., Montgomery, TX, USA). The lactoferrin con-
centrations in the test samples were then quantified by
interpolating their absorbance from the standard curve
generated in parallel with the samples. After factoring for
sample dilutions, lactoferrin concentrations in the original
sample were calculated. Lactoferrin levels were expressed
as ng/mL of the ascitic fluid.
Statistical analyses
All statistical analyses were performed using the SPSS
software package, version 18.0 (SPSS Inc., Chicago, IL,
USA). Descriptive statistics were computed for all variables.
These included medians and percentiles for continuous
factors, and frequencies for categorical factors. A p value
<0.05 indicated statistical significance. Data wereTable 2 Laboratory characteristics of study groups.
Group Aa Group Bb
Leucocyte count (/mm3)
Total count 43.1  17.7 125  1
PMN 3.72  3.39 39.5  4
Albumin level (mg/dL)
Ascitic 0.84  0.66 0.49  0
Serum 2.85  0.45 2.71  0
SAAG 2.20  0.45 2.09  0
Ascitic lactoferrin level (ng/mL) 19.64  6.32 23.64  9
Data are presented as mean  SD.
PMN Z polymorphonuclear leukocyte; SAAG Z serum-ascites albumin
a An ascitic fluid PMN count of <250 cells/mm3 in patients who did
b An ascitic fluid PMN count of <250 cells/mm3 in patients who init
c An ascitic fluid PMN count of 250 cells/mm3.
d An ascitic fluid PMN count of 250 cells/mm3 in patients with pos
e High variance may relate to the difference in lactoferrin levels bepresented as mean  standard deviation for continuous
variables, and as frequency and percentage for categorical
variables. Differences between the groups were evaluated
by an independent sample t test and a chi-square test.
Results
A total of 22 ascites samples were evaluated. Thirteen
patients received antibiotics prior to paracentesis (13/22,
59%). Cirrhosis was related to chronic viral hepatitis alone
in 54.5% (hepatitis B virus Z 8, hepatitis C virus Z 4) of
patients, alcoholism alone in 18.2% (n Z 4), and a combi-
nation of alcoholism and chronic viral hepatitis in 18.2%
(hepatitis B virus Z 2, hepatitis C virus Z 2). In 9.1%
(n Z 2) of patients, cirrhosis was caused by other factors.
Demographic and clinical characteristics of the patients are
presented in Table 1 and laboratory characteristics exam-
ined are shown in Table 2. The mean lactoferrin concen-
tration in patients who did not receive antibiotics (Group A,
n Z 9) was 19.64  6.32 ng/mL. Group A represented the
control group.
Patients who received antibiotics for the treatment
of conditions other than SBP
In Group B (nZ 9), indications for antibiotic use among the
patients included prophylactic antibiotic for gastrointes-
tinal bleeding, pneumonia, urinary tract infection, and
infective endocarditis. SBP was excluded by immediate
evaluation of ascites on arrival to the emergency room.
The mean lactoferrin concentration in Group B was
23.64 9.53 ng/mL, and was not significantly different from
that of Group A (pZ 0.38). However, in patients with clin-
ical sepsis (systemic inflammatory response syndrome and
clinical evidence of infection; nZ 5), the ascitic PMN count
was higher than that in the control group (3.30  3.61/mm3
vs. 51.18  57.11/mm3, p Z 0.02). The mean lactoferrin
concentration was 32.05  8.25 ng/dL. The lactoferrin
concentration was significantly elevated in the patients with
clinical sepsis due to reasons other than SBP, compared with
the control group (Group A, pZ 0.048).Group Cc Group Cpd Group Cn
51.7 653.5  603.5 863.7  556.1 690
2.8 285.8  188.6 386.7  106.2 662.4
.50 0.39  0.40 0.49  0.42 0.10
.39 2.58  0.30 2.67  0.31 2.34
.56 2.19  0.61 2.15  0.71 2.24
.53 197.7  167.7 e 261.69  145.5 6.057
gradient; SBP Z spontaneous bacterial peritonitis.
not initially receive systemic antibiotic treatment.
ially received antibiotic treatment for reasons other than SBP.
itive ascitic culture.
tween positive and negative ascitic cultures.
Table 3 Laboratory data and bacterial culture results of patients with spontaneous bacterial peritonitis.
PMN count (/mm3) at baseline PMN count (/mm3)after
antibiotic treatment
Lactoferrin level (ng/mL) Bacterial culture result/causative
organism
1 662.4 1.4 6.057 Negative
2 2925 263.4 184.996 Enterococcus faecalis
3 10,450 522.5 134.665 Staphylococcus lugdunensis
4 496.8 356.2 465.397 Escherichia coli
PMN Z polymorphonuclear leukocyte.
126 C.-H. Wu et al.Patients diagnosed with SBP
Four patients fulfilled the criteria for SBP on admission to the
emergency room. Table 3 shows the laboratory findings and
bacterial culture results of these patients. The lactoferrin
concentration was checked after 3e7 days of antibiotic
treatment. Three of the four patients exhibited positive
results on bacterial culture. Lactoferrin concentration of the
three patients with positive results on bacterial culture
(Group Cp) was much higher than that of the patient with a
negative result on bacterial culture. The lactoferrin con-
centration was also significantly elevated
(261.69  145.5 ng/mL) in the cases with positive results on
bacterial culture compared to the cases without SBP, in both
Group A (pZ 0.002) and Group B (pZ 0.001). There was no
difference in the lactoferrin concentrations between the
negative culture ascites (6.057 ng/mL) of Groups A and B.Discussion
Lactoferrin is an iron-binding protein that is present mainly
in external secretions such as breast milk and in poly-
morphonuclear neutrophils. The presence of lactoferrin in
body fluids is proportional to the flux of neutrophils, and its
assessment can provide a reliable biomarker for inflam-
mation [10]. Moreover, lactoferrin is widely used as a
biomarker in gastrointestinal disease. Fecal lactoferrin
concentration is a good marker for the differentiation of
inflammatory bowel disease from conditions associated
with noninflammatory diarrhea, such as irritable bowel
disease, and for the evaluation of disease activity of in-
flammatory bowel disease [11]. According to a previous
study, lactoferrin levels in the ascitic fluid can serve as a
sensitive and specific initial screening test for the detection
of SBP in cirrhotic patients with ascites [8].
Patients with cirrhosis have an increased risk of devel-
oping bacterial infection, followed by sepsis and death.
Infection either is present at admission or develops during
hospitalization in approximately 25e35% of patients [12].
SBP, urinary infections, and pneumonia are the most
frequent infections in such patients. In immunocompro-
mised patients with liver cirrhosis, antibiotics should be
promptly administered in cases of suspected clinical
infection. A delay in antibiotic therapy entails a high mor-
tality rate, particularly in patients with SBP.
A positive result on bacterial culture is obtained in some
of the patients with SBP, but the results can be delayed for
several days [13]. The most common organisms isolated in
patients with SBP include Escherichia coli, Gram-positivecocci (mainly Streptococcus species), and enterococci.
These organisms account for approximately 70% of all cases
of SBP [14]. Ascitic fluid with a PMN count of >250/mm3 and
a negative result on bacterial culture is used to indicate
culture-negative neutrocytic ascites [15]. According to a
previous study, SBP with a positive result on ascitic fluid
bacterial culture is associated with a higher mortality than
culture-negative neutrocytic ascites [16].
In the present study, ascitic fluid lactoferrin levels were
assessed in patients with cirrhosis after systemic antibiotic
treatment. We noted that patients who received antibiotic
treatment for conditions other than SBP, such as gastroin-
testinal bleeding, did not show significantly elevated lacto-
ferrin levels compared to those who did not receive antibiotic
treatment and did not have SBP; however, when considering
only the patients who were treated for sepsis, lactoferrin
levels were significantly elevated compared to those who did
not receive antibiotic treatment and did not have SBP, which
is consistent with the results of a previous study [17].
The current study confirmed that ascitic fluid lacto-
ferrin concentration remains elevated in SBP patients with
a positive result on bacterial culture, even after systemic
antibiotic treatment. However, the lactoferrin concen-
tration in the patient with culture-negative neutrocytic
ascites was not elevated compared to the control group. A
possible explanation for the differential lactoferrin con-
centrations between patients with positive and negative
results on bacterial culture is that the increased number of
bacterial colonies present in the patients with positive
results on culture may cause a greater extent of inflam-
mation. A previous study revealed that patients infected
with Clostridium difficile with positive results for stool
toxins had significantly higher fecal lactoferrin levels,
indicative of increased intestinal inflammation [18].
Another study demonstrated that bacterial-related diar-
rhea (diagnosed by the presence of bacterial colonies on
specially prepared agar plates) also led to higher fecal
lactoferrin levels [19].
There are several medications that reduce the concen-
tration of lactoferrin, especially anti-inflammatory medi-
cations that were usedwhen sepsis or systemic inflammation
was suspected. In another study assessing stool lactoferrin
concentration among patients with Crohn’s disease showed
that the use of nonsteroidal anti-inflammatory drugs or
steroids caused the anti-inflammatory effect [20]. In our
study, the elevation of ascitic fluid lactoferrin level is a good
predictive tool for positive ascitic culture. However, larger
prospective studies are required to prove that there is a
reduction in ascitic fluid lactoferrin concentration after
antibiotic treatment.
Lactoferrin in SBP after antibiotic treatment 127The major limitation of this study is the small sample
size. A larger prospective study is required to determine the
cutoff level and the decline in the rate of ascitic fluid lac-
toferrin concentration after systemic antibiotic treatment.
In conclusion, elevated lactoferrin levels in the ascites
of cirrhotic patients with SBP and positive ascitic bacterial
culture appears to be a promising diagnostic predictor,
even after systemic antibiotic treatment.
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